TWO SIGMA SECURITIES, LLC
Broker-DealerPosition in TGTX — Tg Therapeutics, Inc.
CIK 1450144
NEW YORK, NY
Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$328,379
-$40,457 QoQ
Shares Held
9,885
-37.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Dec 31, 2020CallValue
$265,302
CallShares
5,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA SECURITIES, LLC holds $12,245,110 across 97 Biotechnology names. TGTX ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
22,096 | $1,248,203 | |
| 2 | INCY |
Incyte Corp
|
11,772 | $1,107,980 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
23,779 | $956,629 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,135 | $876,946 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
11,908 | $627,789 | |
| 6 | ABVX |
Abivax S.A.
|
3,936 | $438,273 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
6,851 | $345,564 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
This page
|
9,885 | $328,379 |
All Filings in TGTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $328,379 | 9,885 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $368,836 | 15,769 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $151,618 | 10,081 | Shares | Sole | 2023-05-15 | |
| 2020-12-31 | $265,302 | 5,100 | Call | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||